Global Veterinary Molecular Diagnostics Market

Infograph - Global Veterinary Molecular Diagnostics Market

Global Veterinary Molecular Diagnostics Market is expected to grow at a CAGR of 8.23% over the Forecast Period of 2018 – 2024

The molecular diagnostic is a collection of techniques used to analyses biological markers in the genome and proteome. In veterinary molecular diagnostics, samples that are derived from animals are tested. This diagnostic mostly focuses on the identification, genotyping of pathogens and detection. In veterinary diagnosis, these techniques are used to diagnose diseases in individual animals and groups or to assess the disease status of a group. Growing consciousness regarding the importance of molecular diagnostics among veterinarians and the general public in both developed and developing countries for healthy livestock is estimated to drive the global veterinary molecular diagnostics market. Further, increasing the incidence of numerous animal diseases worldwide, and an upsurge in spending on pets are other reasons driving the growth of this market. Additionally, owing to the increasing incidence of foodborne zoonotic diseases worldwide the production of animal has reduced by 15%-20% per year. As per the European food safety authority (EFSA), around 3,20,000 cases of foodborne and zoonotic diseases are reported every year. Therefore, with increasing, consciousness regarding zoonotic diseases such as bird flu and swine flu farm owners are progressively inclining towards the appropriate care of livestock through correct and specific diagnosis.


The report on Global Veterinary Molecular Diagnostics Market covers segments such as product, technology, animal type, disease indication, and end-user. The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The report provides profiles of the companies in the global IDEXX Laboratories, Inc., VCA, Inc., Thermo Fisher Scientific, Inc., Novacyt Group, QIAGEN N.V., Biomedica Medizinprodukte GmbH, HealthGene Corporation, Bioneer, Abaxis, Inc. and Neogen Corporation.